Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Mapkap Kinase 2/3 (MK2/3)

  • Matthias Gaestel
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_531

Synonyms

Historical Background

Formally, all protein kinases downstream to MAP kinases should be regarded as MAPK-activated protein kinases (MKs). This would include ribosomal S6-kinases (RSKs); mitogen- and stress-activated protein kinases (MSKs); MAP kinase-interacting kinases (MNKs); as well as MK2, MK3, and MK5/PRAK (Roux and Blenis 2004). However, due to the specificity of activation, this group of protein kinases is further subdivided (Fig. 1): RSKs are activated by classical ERKs (Erk1/Erk2) and MSKs and MNKs are phosphorylated by both ERKs and p38 MAPK. MK2 and MK3 are the only MKs which are exclusively activated by p38 MAPK. MK5/PRAK has been described as a “p38-regulated and -activated kinase (PRAK),” but its activation by p38 MAPK is challenged, and alternative activation by atypical MAPKs (Erk3/Erk4) is discussed (Gaestel 2006). For historical reasons RSK was designated MAPKAPK 1...
This is a preview of subscription content, log in to check access.

References

  1. Ben-Levy R, Leighton IA, Doza YN, Attwood P, Morrice N, Marshall CJ, et al. Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. EMBO J. 1995;14:5920–30.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Cano E, Doza YN, Ben-Levy R, Cohen P, Mahadevan LC. Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2. Oncogene. 1996;12:805–12.PubMedGoogle Scholar
  3. Chevalier D, Allen BG. Two distinct forms of MAPKAP kinase-2 in adult cardiac ventricular myocytes. Biochemistry. 2000;39:6145–56.CrossRefPubMedGoogle Scholar
  4. Clifton AD, Young PR, Cohen P. A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress. FEBS Lett. 1996;392:209–14.CrossRefPubMedGoogle Scholar
  5. Ehlting C, Ronkina N, Böhmer O, Albrecht U, Bode KA, Lang KS, et al. Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopolysaccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3. J Biol Chem. 2011;286(27):24113–24.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Engel K, Schultz H, Martin F, Kotlyarov A, Plath K, Hahn M, et al. Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif. J Biol Chem. 1995;270:27213–21.CrossRefPubMedGoogle Scholar
  7. Engel K, Kotlyarov A, Gaestel M. Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J. 1998;17:3363–71.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell. 1994;78:1039–49.CrossRefPubMedGoogle Scholar
  9. Gaestel M. MAPKAP kinases – MKs – two’s company, three’s a crowd. Nat Rev Mol Cell Biol. 2006;7:120–30.CrossRefPubMedGoogle Scholar
  10. Gaestel M. What goes up must come down: molecular basis of MAPKAP kinase 2/3-dependent regulation of the inflammatory response and its inhibition. Biol Chem. 2013;394(10):1301–15.CrossRefPubMedGoogle Scholar
  11. Gaestel M, Kotlyarov A, Kracht M. Targeting innate immunity protein kinase signalling in inflammation. Nat Rev Drug Discov. 2009;8(6):480–99.CrossRefPubMedGoogle Scholar
  12. Guess AJ, Ayoob R, Chanley M, Manley J, Cajaiba MM, Agrawal S, et al. Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis. PLoS ONE. 2013;8(1):e54239.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Gum RJ, Young PR. Identification of two distinct regions of p38 MAPK required for substrate binding and phosphorylation. Biochem Biophys Res Commun. 1999;266:284–9.CrossRefPubMedGoogle Scholar
  14. Hegen M, Gaestel M, Nickerson-Nutter CL, Lin LL, Telliez JB. MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J Immunol. 2006;177:1913–7.CrossRefPubMedGoogle Scholar
  15. Kim YJ, Shuman J, Sette M, Przybyla A. Phosphorylation pattern of a 25 Kdalton stress protein from rat myoblasts. Biochem Biophys Res Commun. 1983;117:682–7.CrossRefPubMedGoogle Scholar
  16. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol. 1999;1:94–7.CrossRefPubMedGoogle Scholar
  17. Lehner MD, Schwoebel F, Kotlyarov A, Leist M, Gaestel M, Hartung T. Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection. J Immunol. 2002;168:4667–73.CrossRefPubMedGoogle Scholar
  18. Mackenzie KF, Wallace DA, Hill EV, Anthony DF, Henderson DJP, Houslay DM, et al. Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation. Biochem J. 2011;435(3):755–69.CrossRefPubMedGoogle Scholar
  19. Maitra S, Chou C-F, Luber CA, Lee K-Y, Mann M, Chen C-Y. The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA. 2008;14(5):950–9.PubMedPubMedCentralCrossRefGoogle Scholar
  20. McLaughlin MM, Kumar S, McDonnell PC, Van Horn S, Lee JC, Livi GP, et al. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem. 1996;271:8488–92.CrossRefPubMedGoogle Scholar
  21. Menon MB, Tiedje C, Lafera J, Ronkina N, Konen T, Kotlyarov A, et al. Endoplasmic reticulum-associated ubiquitin-conjugating enzyme Ube2j1 is a novel substrate of MK2 (MAPKAP kinase-2) involved in MK2-mediated TNFα production. Biochem J. 2013;456(2):163–72.CrossRefPubMedGoogle Scholar
  22. Mourey RJ, Burnette BL, Brustkern SJ, Daniels JS, Hirsch JL, Hood WF, et al. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation. J Pharmacol Exp Ther. 2010;333:797–807.CrossRefPubMedGoogle Scholar
  23. Neininger A, Kontoyiannis D, Kotlyarov A, Winzen R, Eckert R, Volk HD, et al. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J Biol Chem. 2002;277:3065–8.CrossRefPubMedGoogle Scholar
  24. Plath K, Engel K, Schwedersky G, Gaestel M. Characterization of the proline-rich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro. Biochem Biophys Res Commun. 1994;203:1188–94.CrossRefPubMedGoogle Scholar
  25. Ronkina N, Kotlyarov A, Dittrich-Breiholz O, Kracht M, Hitti E, Milarski K, et al. The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol Cell Biol. 2007;27:170–81.CrossRefPubMedGoogle Scholar
  26. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994;78:1027–37.CrossRefPubMedGoogle Scholar
  27. Rousseau S, Morrice N, Peggie M, Campbell DG, Gaestel M, Cohen P. Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs. EMBO J. 2002;21:6505–14.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68:320–44.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WF, Blackwell TK, et al. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 2004;23:1313–24.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Stokoe D, Engel K, Campbell DG, Cohen P, Gaestel M. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett. 1992;313:307–13.PubMedCrossRefGoogle Scholar
  31. Tanoue T, Maeda R, Adachi M, Nishida E. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J. 2001;20:466–79.PubMedPubMedCentralCrossRefGoogle Scholar
  32. Tiedje C, Ronkina N, Tehrani M, Dhamija S, Laass K, Holtmann H, et al. The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation. PLoS Genet. 2012;8(9):e1002977.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Tiedje C, Holtmann H, Gaestel M. The role of mammalian MAPK signaling in regulation of cytokine mRNA stability and translation. J Interf Cytokine Res. 2014;34(4):220–32.CrossRefGoogle Scholar
  34. Tiedje C, Lubas M, Tehrani M, Menon MB, Ronkina N, Rousseau S, et al. p38 MAPK/MK2-mediated phosphorylation of RBM7 regulates the human nuclear exosome targeting complex. RNA. 2015;21(2):262–78.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Wei Y, An Z, Zou Z, Sumpter R, Su M, Zang X, et al. The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation. eLife. 2015;4:e05289.Google Scholar
  36. White A, Pargellis CA, Studts JM, Werneburg BG, Farmer 2nd BT. Molecular basis of MAPK-activated protein kinase 2: p38 assembly. Proc Natl Acad Sci USA. 2007;104:6353–8.PubMedPubMedCentralCrossRefGoogle Scholar
  37. Zaru R, Ronkina N, Gaestel M, Arthur JSC, Watts C. The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat Immunol. 2007;8(11):1227–35.PubMedPubMedCentralCrossRefGoogle Scholar
  38. Zu YL, Wu F, Gilchrist A, Ai Y, Labadia ME, Huang CK. The primary structure of a human MAP kinase activated protein kinase 2. Biochem Biophys Res Commun. 1994;200:1118–24.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Hannover Medical SchoolInstitute of Cell BiochemistryHannoverGermany